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Abstract
Background: Despite the risk of new persistent opioid use after cardiac surgery, post-discharge opioid
use has not been quantified and evidence-based prescribing guidelines have not been established.
Methods: Opioid-naïve patients undergoing primary cardiac surgery via median sternotomy between
January–December 2019 at 10 hospitals participating in a statewide collaborative were selected. Clinical
data were linked to patient-reported outcomes collected at 30-day follow-up. An opioid prescribing

of

recommendation stratified by inpatient opioid use on the day before discharge (0, 1–3, or ≥4 pills) was

ro

implemented in July 2019. Interrupted time-series analyses were performed for prescription size and postdischarge opioid use before (January–June) and after (July–December) guideline implementation.

-p

Results: Among 1495 patients (729 pre- and 766 post-recommendation), median prescription size

re

decreased from 20 to 12 pills after recommendation release (p<0.001), while opioid use decreased from 3

lP

to 0 pills (p<0.001). Change in prescription size over time was +0.6 pills/month before and -0.8

na

pills/month after the recommendation (difference: -1.4 pills/month, p=0.036). Change in patient use was
+0.6 pills/month before and -0.4 pills/month after the recommendation (difference: -1.0 pills/month,

ur

p=0.017). Pain levels during the first week after surgery and refills were unchanged. Patients using 0 pills

Jo

before discharge (n=710) were prescribed a median of 0 pills and used 0, while those using 1–3 pills
(n=536) were prescribed 20 and used 7, and those using ≥4 pills (n=249) were prescribed 32 and used 24.
Conclusions: An opioid prescribing recommendation was effective, and prescribing after cardiac surgery
should be guided by inpatient use.

Abstract Word Count: 250
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Opioid overprescribing after surgery is common.1–6 A larger opioid prescription size has been
associated with higher opioid use6 and an increased risk of new persistent opioid use 3-6 months after
surgery in previously opioid-naive patients.8 New persistent opioid use has been reported in 3-8% of
patients after minor and major surgery,9–11 over 10% of cancer patients undergoing curative surgery,12 and
up to 17% of patients undergoing cardiothoracic surgery.8,13–15 In addition, overprescribing has been
shown to increase the risk of opioid overdose in patients’ family members through opioid diversion.16

of

Despite high rates of new persistent opioid use and large prescription sizes at discharge,8,14,17

ro

patient-reported opioid use after cardiac surgery has not been described and evidence-based prescribing
guidelines have not been established. With the sharp rise of opioid-related drug overdoses17 prompting the

-p

declaration of the opioid crisis as a public health emergency, considerable efforts to reduce opioid use

re

through evidence-based prescribing guidelines after general surgery procedures have been largely

lP

successful.1,5,18–20 However, many of these guidelines were established for outpatient procedures, and may
not translate to cardiac surgery since patients undergo median sternotomy and spend a median 6–12 days

na

in the hospital, depending on procedure.21 A single-center study of inpatient general surgery found that

ur

inpatient opioid use prior to discharge was associated with post-discharge use and could be utilized to

Jo

guide prescribing through an individualized approach,22 which may be similarly beneficial in cardiac
surgery patients. At present, appropriate opioid prescription quantities after cardiac surgery remain
unknown and the relationship between inpatient and post-discharge use has not been characterized. Over
300,000 cardiac surgery procedures are performed annually and these procedures confer among the
highest published rates of new persistent opioid use. Therefore, establishing evidence-based opioid
prescribing recommendations should be prioritized to guide responsible prescribing and optimize patient
care.
This prospective, multicenter collaboration was organized to: 1) define opioid prescribing and
patient-reported use after cardiac surgery; 2) assess inpatient opioid use as a predictor of post-discharge
opioid use; 3) establish opioid prescribing recommendations for opioid-naive patients; and 4) evaluate the
implementation of statewide recommendations by analyzing post-intervention prescribing and patient-
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reported outcomes (PROs). We hypothesized that implementing recommendations would decrease both
opioid prescribing and use and that incorporating inpatient opioid use would allow for more personalized
prescribing.
Patients and Methods
This study was deemed exempt by the University of Michigan Institutional Review Board
(HUM00156194).

of

Data Source

ro

Clinical data were collected through the Michigan Society of Thoracic and Cardiovascular
Surgeons Quality Collaborative (MSTCVS-QC), developed in 2001 as a cardiac surgeon-led quality

-p

collaborative embedded in the MSTCVS including all 33 non-federal hospitals performing cardiac

re

surgery in Michigan. The Collaborative receives standardized harvest files sent by each of the hospitals to

lP

the Society of Thoracic Surgeons (STS) national database.

na

Opioid-naive was defined as not using opioids at time of admission for surgery. PROs including
postoperative pain scores, number of pills used post-discharge, number of days using an opioid, refills,

ur

and use of adjuncts were captured in an 11-item questionnaire prospectively administered at 30-day

Jo

clinical follow-up (eAppendix 1). Inpatient opioid use during the 24-hour calendar day before discharge
and prescription information were collected through chart review by data management team members at
each hospital. Although perioperative patient instructions were not uniform across all 10 centers, each
patient receiving an opioid prescription at all 10 centers reviewed the Opioid Start Talking form
(eAppendix 2) with a provider according to state law.
Questionnaire responses were collected and managed using REDCap (Research Electronic Data
Capture) tools hosted at the MSTCVS Coordinating Center.23 Questionnaire responses were linked to
clinical data by unique STS record identification numbers and verified with dates of surgery and
discharge.
Patient Population
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Patients undergoing cardiac surgery via median sternotomy between January–December 2019 at
10 centers participating in the MSTCVS-QC were identified (n=3650). From these, operative mortalities
(n=153), those with postoperative length of stay >30 days (n=74), discharge to a location other than home
(n=612), and reoperations (n=268) were sequentially excluded. From the resulting population (n=2543),
1685 (66%) reported PROs, including 1495 (89%) opioid-naive patients (Figure 1). Clinical
characteristics, inpatient opioid use, and prescription size were collected for all patients and compared

of

between responders and non-responders.

ro

Opioid Prescribing Recommendations

Opioid prescribing and PROs from January–March 2019 were analyzed to form an initial

-p

recommendation. The final recommendation was established through multidisciplinary input from the

re

Michigan Opioid Prescribing Engagement Network, hospital data managers, and surgeon leaders from all

lP

10 centers (Figure 2). This recommendation was formed in June and disseminated in early July.

na

Throughout the 1-year study period, all 10 hospitals collected day before discharge opioid use,
prescribing data, and PROs at follow-up. The pre-recommendation period was defined by operative dates

Jo

Statistical Analysis

ur

January 1–June 30, while the post-recommendation period included July 1–December 31.

Primary outcomes were prescription size and patient-reported, post-discharge opioid use.
Secondary outcomes included inpatient opioid use before discharge, refills prior to follow-up, percent of
patients not prescribed an opioid at discharge, and PROs including pain in the first week after surgery
(with 1 denoting “none,” 2 “minimal,” 3 “moderate,” and 4 “severe”) and use of non-opioid adjuncts.
Bivariate comparisons utilized paired, two-tailed t-tests or Wilcoxon rank-sum tests for
continuous data and chi-squared testing for categorical data, as appropriate. All opioid prescription and
use data were initially converted to oral morphine equivalents and quantified in 5-mg oxycodone pills.
Opioid prescribing and use was quantified in median (interquartile range, IQR) and mean ± standard
deviation (SD) number of pills. Prescription size and patient-reported use were evaluated overall and by
hospital. Interrupted time-series analyses were performed comparing discharge opioid prescription size
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and post-discharge use pre- and post-recommendation. The slope during each period represents the trend
in number of pills per month, while both the differences in prescription size and post-discharge use (level
change) and the difference in the trends of each before and after the recommendation release (trend
change) were evaluated. The percent of patients not prescribed an opioid at discharge, opioid refill rate,
and pain levels were displayed by 3-month periods to show trends related to the release of
recommendations.

of

As in prior analyses,22 the unadjusted relationship between prescribing and post-discharge use

ro

was depicted after stratifying groups by opioid use on the day before discharge (0, 1–3, or ≥4 pills).
Group definitions were consistent with the terciles of inpatient opioid use determined by the initial data

-p

used to develop the prescribing recommendation. Guideline adherence was measured by quantifying the

re

number of patients in each tercile who were prescribed the recommended number of pills or fewer as

lP

outlined in Figure 2. Univariate analyses of post-discharge opioid use were performed with Wilcoxon

na

rank-sum tests for binary variables or else negative binomial regression. Multivariable mixed-effects
negative binomial regression was performed to identify independent predictors of post-discharge opioid

ur

use. The primary exposure was inpatient opioid use during the day before discharge, while covariates

Jo

included age, sex, race, ethnicity, primary insurance payor, diabetes, cerebrovascular disease,
hypertension, smoking history (non-smoker, former smoker, active smoker), peripheral vascular disease,
heart failure, cancer within 5 years, depression, postoperative complication, operative status (elective,
urgent, or emergent), pain during the first week after surgery, length of stay, surgery type, and hospital
(random effect).
Statistical significance was defined as a p-value <0.05. All analyses were performed in Stata 16.0
(StataCorp LLC, College Station, TX).
Results
Patient Demographics and Outcomes
Among 2257 eligible opioid-naive patients, respondents (n=1495) compared to non-respondents
(n=762) were prescribed 2 less pills at discharge, had a mean 0.5-day shorter hospital stay, and a lower
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proportion had a history of depression; patient demographics, clinical characteristics, and inpatient opioid
use on the before discharge were otherwise similar (eTable 1). Among 1495 opioid-naive respondents
across 10 centers, mean age was 64±11 years and 26% were female. In total 55% underwent isolated
CABG, 30% isolated valve, and 12% CABG/valve procedures, most of which were elective (n=892,
60%). A higher proportion of post- compared to pre-recommendation patients had a history of
hypertension, underwent isolated CABG, and were urgent rather than elective; preoperative

of

characteristics otherwise did not statistically differ by study period (Table 1).

ro

Mean postoperative length of stay was statistically shorter post-recommendation compared to
pre-recommendation (6.5±3.0 vs. 6.9±3.0 days, p=0.027), whereas complication rate did not differ (post:

-p

289/766 [38%] vs. pre: 302/729 [41%], p=0.14). Inpatient opioid use on the day before discharge

lP

Opioid Prescribing and Post-Discharge Use

re

decreased from median 0.7 (0–2.7) to 0.6 (0–2.0) pills (p=0.023) [Table 1].

na

Median prescription size decreased from 20 (0–37) pre-recommendation to 12 (0–24) pills postrecommendation (p<0.001), while post-discharge use decreased from 3 (0–16) to 0 (0–11) pills (p<0.001)

ur

and varied by hospital (eFigure 1). Interrupted time series analyses showed a significant difference

Jo

between pre- and post-recommendation prescribing (p=0.003) and use (p=0.002). The change in
prescription size over time was +0.6 pills/month (95% CI, -0.2 to +1.4) before and -0.8 pills/month (95%
CI, -1.8 to +0.2) after the recommendation, representing a significant difference in slope of -1.4
pills/month (95% CI, -2.7 to -0.1; p=0.036). The change in post-discharge use was +0.6 pills/month (95%
CI, +0.1 to +1.2) before and -0.4 pills/month (95% CI, -1.0 to +0.2) after the recommendation,
representing a significant difference in slope of -1.0 pills/month (95% CI, -1.8 to -0.2 pills; p=0.017)
[Figure 3].
Patient-Reported Outcomes
While a higher proportion of patients were not prescribed an opioid at discharge after the release
of recommendations (pre: 25.2% vs. post: 32.6%, p=0.002), opioid refill rate (pre: 13.1% vs. post: 13.8%,
p-trend=0.93) and patient-reported pain levels during the first week after surgery (p-trend=0.89) did not
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significantly change (Figure 4). Additionally, patient-reported use of non-opioid adjuncts increased from
51% (353/687) pre-recommendation to 61% (435/715) post-recommendation (p<0.001). PROs before and
after recommendation release varied by hospital (eFigure 2) and were collected at a median 29 (25–36)
days after discharge, which did not differ pre- versus post-recommendation (29 [25–35] vs. 29 [25–37]
days, p=0.21).
Stratification by Inpatient Opioid Use and Guideline Adherence

of

Among the 47% (710/1495) of patients who used 0 pills on the day before discharge, nearly half

ro

(316/710, 45%) were still prescribed a median 19 (IQR 12–28) pills. Utilizing the same groupings of
inpatient use as in the prescribing recommendations (0 pills [n=710], 1–3 pills [n=536], and ≥4 pills

-p

[n=249]), both prescription size and post-discharge use increased significantly with each group of

re

increasing inpatient use (Figure 5). Median prescription size was greater than post-discharge use for

lP

patients with inpatient use before discharge in all 3 groups: 0 pills (prescription size: 0 [0–18] vs. use: 0

na

[0–0], p<0.001), 1–3 pills (prescription size: 20 [13–28] vs. use: 7 [1–17], p<0.001), and ≥4 pills prior to
discharge (prescription size: 32 [24–40] vs. use: 24 [10–40], p<0.001). Median postoperative length of

ur

stay for each group was 6 (5–8), 6 (5–7), and 5 (5–7) days, respectively. Among post-recommendation

Jo

patients, 52% (397/766) were prescribed a number of opioid pills adherent to the prescribing
recommendations, whereas 35% (254/729) of pre-recommendation patients were prescribed quantities
adherent to the recommendation (p<0.001).
Predictors of Post-Discharge Use
Multivariable analysis indicated that inpatient opioid use the day before discharge was
independently predictive of post-discharge opioid use. Additional predictors of post-discharge use
included younger age, absence of cerebrovascular disease, absence of cancer within the past 5 years,
patients with Medicare rather than no insurance, higher pain levels, and shorter postoperative length of
stay (Table 2).
Comment
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In this multicenter collaboration to establish, implement, and evaluate opioid prescribing
recommendations after cardiac surgery, both opioid prescribing and patient-reported use decreased
significantly, while patient-reported pain levels and opioid refills remained unchanged. In addition, use of
non-opioid adjuncts and the proportion of patients not prescribed an opioid at discharge increased after
release of the recommendations. Collectively, these findings suggest that inpatient opioid use should
guide prescribing and that the proposed opioid prescribing recommendations for opioid-naive patients

of

undergoing cardiac surgery (Figure 2) were effective. Moreover, postoperative opioid use continued to

ro

decline, suggesting future efforts could employ more aggressive opioid-sparing approaches.
Opioid prescribing guidelines have been successfully implemented for a wide range of

-p

procedures.5,18–20 However, many of these procedures are outpatient or involve a short hospital stay,

re

whereas cardiac surgery patients may spend a week or more as an inpatient. Administrative claims

lP

analyses have described new persistent opioid use after cardiac7,10,13,16 and general thoracic7,9,11,12,14

na

procedures and efforts have been initiated to establish thoracic surgery prescribing guidelines.4 However,
the implementation of these thoracic guidelines has not been evaluated and only recommendations based

ur

on single-center expert opinion have been proposed for cardiac surgery.24 A study of inpatient general

Jo

surgery concluded that inpatient opioid use before discharge should guide prescribing, rather than a single
prescription quantity.22 Our study reinforces these findings in a cardiac surgery population and expands
these data by implementing a stratified, 4-part prescribing and pain management recommendation across
10 hospitals. Interestingly, only 11% of patients undergoing thoracic4 and 15% of patients undergoing
inpatient general surgery22 were not prescribed an opioid at discharge, versus 29% of cardiac patients in
this study. However, we also found that among the 47% of patients not using opioids on the day before
discharge, 45% were still prescribed an opioid. Future efforts at reductions in prescribing should focus on
patients not using opioids prior to discharge, as this cohort appears to require few if any opioids after
discharge.
Importantly, patient-reported pain scores during the first week after surgery remained stable after
guideline release, at a mean between 1 (“none”) and 2 (“minimal”), qualitatively lower than prior general
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surgery studies utilizing the same scale.19 Although opioid refill rates also did not change, the overall rate
was 13.4% (hospital range, 3.4%–23.3%; eFigure 2D), substantially higher than published rates of
0.4%,18 3.2%,5 and 6.5%22 in major general surgery series. The high overall refill rate and substantial
hospital variation in conjunction with a 29% rate of patients not prescribed an opioid at discharge together
highlight the wide variability in opioid requirements among cardiac surgery patients, supporting a more
individualized approach to prescribing compared to other surgical procedures. Variation in these data

of

across hospitals may also reflect differences in implementation, as well as the overall adherence to these

ro

recommendations for only 52% of patients overall. Given the effectiveness demonstrated in this study,
future efforts examining the barriers and facilitators of implementation will be critical for sustainable

-p

change. For example, hospital practices in handling refill requests varied widely amongst collaborating

re

centers, depending on factors such as patient driving distance to the hospital and/or resources to support

lP

in-person clinical assessments. The emergence of the COVID-19 pandemic could further impact and

na

exacerbate existing barriers to in-person assessments for postoperative pain. Patients may feel hesitant or
fearful to return for clinical assessment due to COVID-19 concerns. Providers may increase prescription

ur

sizes to counteract the increased barriers to in-person follow-up during the pandemic or more readily

Jo

prescribe refills. These practice patterns and challenges should be continually assessed, depending on
local factors including COVID-19 prevalence, hospital resources, and patient preferences.
Independent predictors of high post-discharge opioid use included younger age, shorter
postoperative length of stay, higher inpatient opioid use, and higher patient-reported pain levels. Younger
age was also identified as an independent predictor of post-discharge opioid use after general surgery6,22
and has additionally been identified as an independent predictor of new persistent opioid use 3-6 months
after thoracic,7,10,12 cardiac,7,10 and other types of major elective surgery.10 Shorter length of stay as a
predictor of higher post-discharge opioid use reinforces the principle that cardiac patients should not be
treated uniformly, but rather stratified depending on inpatient requirements before discharge. In doing so,
we identified distinct cohorts, with 47% of patients not using opioids the day before discharge and a
median 0 pills after discharge, whereas patients using ≥4 pills before discharge used a median 24 pills
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post-discharge (Table 2 and Figure 5). Since opioid-naive status was defined at admission, the cohort
with increased opioid requirements may have had recent or remote opioid use, which may have altered
their opioid tolerance and thresholds for adequate pain relief. In addition, the group with higher use could
be due to a shorter length of stay, although the significance of this difference between groups (median 6
vs. 5 days) is unclear without collecting data on earlier inpatient use.
The clinical significance of a 0.1 pill decrease in the median opioid use on the day before

of

discharge is unclear, but the significant trend of decreasing inpatient opioid use during the study may

ro

represent improved inpatient opioid weaning. Although not measured in this study, perioperative opioidsparing analgesia and early inpatient opioid weaning may further reduce prescribing and post-discharge

-p

use and have been described as components of cardiac enhanced recovery after surgery (ERAS)

re

pathways.25–27 ERAS programs comprehensively address perioperative management, but remain difficult

lP

to formally evaluate due to inconsistent compliance and multiple competing interventions, and have not

na

consistently addressed opioid prescribing.25–27 Since this prescribing recommendation stratifies patients
by inpatient use before discharge rather than a single quantity, it could be integrated into any existing

ur

perioperative pain management program to meet the needs of a diverse spectrum of cardiac surgery

Jo

patients. Finally, this recommendation should be continually reassessed through learning health system
principles of quality improvement based on routine practice data.28
This study has several limitations. First, PROs are subject to recall bias. To partially mitigate this,
outcomes were collected in a standardized questionnaire at a relatively consistent interval after discharge
(median 29 [25–36] days). Second, PROs were provided by 66% of the total population which may
impact the generalizability of these data. However, clinical characteristics, inpatient opioid use, and
prescribing data were collected for 100% of patients and differences between responders versus nonresponders were minimal. Furthermore, a 66% response rate compares favorably to the 56% rate reported
in prior work utilizing similar methodology.19 Finally, inpatient non-narcotic pain protocols were not
standardized across hospitals during the study period and may have influenced pain management.
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However, the impact of differing inpatient protocols likely remained consistent before and after guideline
implementation at individual centers.
In conclusion, opioid prescribing decreased by 40% and post-discharge opioid use decreased
from a median of 3 to 0 pills, while pain levels and refills did not change after implementation of an
opioid prescribing recommendation based on inpatient opioid use. The proposed guidelines appeared
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of

effective and should be continually reassessed through a learning health system framework.
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Table 1: Patient characteristics.
Variable,
mean±std or n (%)

Overall
(n=1495)

Pre-recommendation
(January–June, n=729)

Post-recommendation
(July–December, n=766)

P-value

64±11

63±11

64±11

0.07

Female sex

382(26)

173(24)

209(27)

0.12

Body mass index

29.7±5.7

29.8±5.7

29.6±5.7

0.54

1296(87)

630(86)

666(87)

Black

103(7)

54(7)

49(6)

Non-Caucasian, non-black

47(3)

23(3)

24(3)

Not stated

49(3)

22(3)

Diabetes

555(37)

256(35)

Hypertension

1246(83)

591(81)

Cerebrovascular disease

310(21)

Peripheral vascular disease

157(11)

Congestive heart failure

525(35)

Age

Race, %

of

0.84

ro

27(4)
0.11

655(86)

0.021

137(19)

173(23)

0.07

79(11)

78(10)

0.69

270(37)

255(34)

0.15

54(7)

41(5)

0.11

128(18)

149(20)

0.33

613(41)

307(42)

306(40)

625(42)

303(42)

322(42)

256(17)

119(16)

137(18)

822(55)

371(51)

451(59)

446(30)

228(31)

218(28)

181(12)

101(14)

80(10)

46(3)

29(4)

17(2)

Elective

892(60)

456(63)

436(57)

Urgent

561(38)

249(34)

312(41)

42(3)

24(3)

18(2)

Postoperative length of stay

6.7±3.0

6.9±3.0

6.5±3.0

0.027

Postoperative complication

591(40)

302(41)

289(38)

0.14

Inpatient opioid use on day
before discharge, median
(interquartile range) in 5mg
oxycodone pills

0.7(0–2.4)

0.7(0–2.7)

0.6(0–2.0)

0.023

Depression

277(19)

Smoking status, %
Never smoker

Isolated valve

Jo

Current smoker
Isolated CABG

re

ur

Former smoker
Procedure, %

95(6)

lP

Cancer within 5 years

CABG/valve
Other

-p

299(39)

na

Caucasian

0.61

0.005

Operative acuity, %

Emergent

0.024
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Table 2: Independent predictors of post-discharge opioid use after cardiac surgery (full model in eTable
2).
Pills taken after
discharge, median (IQR)

Pills taken after
discharge, mean±SD

<60(n=510)

5(0-21)

14±20

60-69(n=487)

1(0-14)

9±15

≥70(n=498)

0(0-4)

4±9

Univariate Multivariable
p-value
p-value

Age*
<0.001

<0.001

0.23

0.013

0.24

0.049

0(0-12)

No(n=1120)

1(0-13)

Cancer Within the Past 5 Years

9±15
9±16

ro

Yes(n=286)

of

Cerebrovascular disease

0(0-10)

No(n=1308)

1(0-13)

9±16

-p

Yes(n=91)

re

Primary insurance payor§

7±13

7±13

0(0-0)

2±7

0.08

0.011

12(0-37)

19±21

<0.001

0.50

0(0-10)

9±18

0.51

0.89

4(0-17)

11±16

0.001

0.48

3(0-14)

10±15

0.09

0.61

0

2±5

7(1-17)

11±13

<0.001

<0.001

24(10-40)

28±23

0

2±7

Minimal(n=418)

0(0-3)

4±9

0.001

0.001

Moderate(n=683)

3(0-14)

10±15

<0.001

<0.001

Severe(n=238)

14(2-28)

19±22

<0.001

<0.001

3-5 days(n=615)

3(0-17)

11±17

6-7 days(n=487)

1(0-12)

9±15

<0.001

0.004

≥8 days(n=393)

0(0-9)

7±14

0(0-9)

lP

Medicare(ref, n=761)
Self-pay/no insurance(n=15)

na

Medicaid(n=113)
Military/other governmental(n=35)
Commercial(n=437)

ur

Health maintenance organization(n=134)

Reference

0 pills(n=710)
1 to 3 pills(n=536)
≥4 pills(n=249)
st

Jo

Number of pills taken on day before discharge*

Pain during the 1 week after surgery

§

None(n=80)

Reference

Length of stay*

*Analyzed as a continuous variable in multivariable regression.
§
Analyzed as a categorical variable in multivariable regression.
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Figure Legends
Figure 1: Patient population STROBE diagram.
Figure 2: Opioid prescribing recommendations for opioid-naïve patients undergoing cardiac surgery.
Figure 3: Interrupted time-series analyses of opioid prescription size and patient-reported post-discharge
opioid use before and after release of prescribing guidelines.
Figure 4: Percent of patients without an opioid prescription at discharge, refill rate, and patient-reported

ro

of

pain scores.

Figure 5: Opioid prescription size (blue) and patient-reported post-discharge opioid use (red) stratified by

Jo

ur

na

lP

re

-p

the amount of opioid use during the inpatient day before discharge (0, 1–3, or ≥4 pills).
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